Company Filing History:
1 out of 2,405 
1 out of 7 
1 out of 769 
Years Active: 2017
Title: The Innovative Contributions of Elena Capito
Introduction
Elena Capito is a notable inventor based in Pommezia, Italy. She has made significant strides in the field of metabolic disorder treatments, particularly focusing on diabetes and obesity. Her work has led to the development of innovative peptide analogs that have the potential to improve patient outcomes.
Latest Patents
Elena Capito holds 1 patent for her invention titled "Oxyntomodulin analogs." This patent describes peptide analogs of oxyntomodulin (OXM, glucagon-37) that have been modified to resist cleavage and inactivation by dipeptidyl peptidase IV (DPP-IV). These modifications increase the in vivo half-life of the peptide analog while enabling it to act as a dual GLP-1/glucagon receptor (GCGR) agonist. The peptide analogs are particularly useful for treating metabolic disorders such as diabetes and obesity.
Career Highlights
Throughout her career, Elena has worked with prominent companies in the pharmaceutical industry, including Merck Sharp & Dohme Corporation and MSD Italia S.r.l. Her contributions to these organizations have been instrumental in advancing research and development in metabolic health.
Collaborations
Elena Capito has collaborated with esteemed colleagues such as Paul E. Carrington and George J. Eiermann. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Elena Capito's work exemplifies the impact of innovative thinking in the field of medicine. Her patented peptide analogs represent a significant advancement in the treatment of metabolic disorders, showcasing her dedication to improving health outcomes.